PMP22 and Charcot-Marie-Tooth disease type 1A: AAV vector-based delivery of miR871 by lumbar intrathecal injection into C61-het mice, another CMT1A model, effectively transduced SCs in peripheral nerves and reduced PMP22 mRNA and protein expression [515].